SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-064020
Filing Date
2013-08-14
Accepted
2013-08-14 17:49:19
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13907_110q.htm 10-Q 1354985
2 EX-31.1 a13-13907_1ex31d1.htm EX-31.1 12813
3 EX-31.2 a13-13907_1ex31d2.htm EX-31.2 13285
4 EX-32.1 a13-13907_1ex32d1.htm EX-32.1 4693
5 EX-32.2 a13-13907_1ex32d2.htm EX-32.2 5146
  Complete submission text file 0001104659-13-064020.txt   13993081

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cycc-20130630.xml EX-101.INS 1204185
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycc-20130630.xsd EX-101.SCH 119202
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycc-20130630_cal.xml EX-101.CAL 93510
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cycc-20130630_lab.xml EX-101.LAB 1630836
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycc-20130630_pre.xml EX-101.PRE 867918
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycc-20130630_def.xml EX-101.DEF 535341
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 131039003
SIC: 2834 Pharmaceutical Preparations